|Company||Cardinal Health, Inc.|
|Headquarters||7000 Cardinal Place, Dublin, Ohio 43017, USA|
|Chairman and CEO||George S. Barrett|
|CFO||Michael C. Kaufmann|
|Founder||Robert D. Walter|
|NYSE stock symbol||CAH|
|Revenue||$102.531 billion (2015)|
|Net income||$1,215 million (2015)|
|Earnings per share||$3.62 USD (2015)|
|Corporate contact number:||614-757-5000|
|Investor relations contact number:||614-757-4757|
|Investor relations contact number:||[email protected]|
Cardinal Health, Inc. is a health care services company that specializes in drug development services for the biotechnology and pharmaceutical industry.
The company claims that it provides medical products and services to more than 100,000 locations on a daily basis.
It is a leader in the manufacturing of certain medical and surgical products, such as gloves, fluid management products and surgical apparel.
Cardinal Health also operates the country’s most extensive network of radio-pharmacies.
As of May 2014, Cardinal Health is a Fortune 500 company, with a team of approximately 33,000 employees around the world.
The company is has two main business segments:
Pharmaceutical Segment: this segment focuses on providing pharmaceuticals and specialty plasma products to healthcare providers and pharmaceutical manufacturers. It integrates products from hundreds of manufacturers into site-specific deliveries.
Medical Segment: this segment focuses on delivering medical-surgical products and manufacturing medical products such as gloves, gowns, surgical drapes, scrubs and fluid management products.
Cardinal Health was originally founded in 1971 by Robert D. Walter under the name “Cardinal Foods”. At the beginning the company was a food wholesaler.
Through the acquisition of the Bailey Drug Company in 1979, the company changed its name to Cardinal Distribution, Incorporated. and began wholesaling drugs.
The company, which is based in Dublin, Ohio, is publicly traded on the New York Stock Exchange (NYSE) under the stock ticker symbol ‘CAH’.
It announced in 2013 that it would work along with CVS Caremark to create the largest generic drug sourcing operation in the US. According to the company, the venture will begin in July 2014.
|Income data (in $ millions)||2015*||2014*|
|Cost of products sold||$96,819||$85,923|
|Distribution, selling, general and administrative expenses||$3,240||$3,028|
|Restructuring and employee severance||$44||$31|
|Amortization and other acquisition-related costs||$281||$223|
|Impairments and (gain)/loss on disposal of assets||$(19)||$15|
|Litigation (recoveries)/charges, net||$5||$(21)|
|Other income, net||$(7)||$(46)|
|Interest expense, net||$141||$133|
|Earnings before income taxes and discontinued operations||$1,967||$1,798|
|Provision for income taxes||$755||$635|
|Earnings from continuing operations||$1,212||$1,163|
|Earnings/(loss) from discontinued operations, net of tax||$3||$3|
|Balance sheet data (in $ millions)|
|Total current liabilities||$17,243||$15,115|
|Long-term obligations, less current portion||$5,211||$3,171|
|Deferred income taxes and other liabilities||$1,432||$1,346|
|Total shareholders’ equity||$6,256||$6,401|
|Common share data (in $)|
|Earnings per Common Share – Basic||$3.66||$3.42|
|Earnings per Common Share – Diluted||$3.62||$3.38|
|Cash flow data (in $ millions)|
|Net cash provided by operating activities||$2,540||$2,524|
|Net cash used in investing activities||$(849)||$(850)|
|Net cash provided by/(used in) financing activities||$60||$(710)|
|Cash and cash equivalents at beginning of period||$2,865||$1,901|
|Cash and cash equivalents at end of period||$4,616||$2,865|
*Years Ended June 30
Source: “Cardinal Health, Inc. Form 10-K 2015”